Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention.
Nayan AgarwalDhruv MahttaCecil A RambaratAkram Y ElgendyAhmed N MahmoudPublished in: BioMed research international (2018)
Management of patients on long-term anticoagulation requiring percutaneous coronary intervention is challenging. Triple therapy with oral anticoagulant and dual antiplatelet therapy is the standard of care. However, there is no strong evidence to support this strategy. There is emerging data regarding the safety and efficacy of dual therapy with oral anticoagulant and single antiplatelet therapy in these patients. In this comprehensive review we highlight available evidence regarding various antithrombotic regimens' efficacy and safety in patient with coronary artery disease undergoing percutaneous coronary intervention with long-term anticoagulation therapy requirements.
Keyphrases
- percutaneous coronary intervention
- antiplatelet therapy
- atrial fibrillation
- coronary artery disease
- st segment elevation myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery bypass grafting
- venous thromboembolism
- coronary artery bypass
- end stage renal disease
- healthcare
- cardiovascular events
- ejection fraction
- palliative care
- newly diagnosed
- electronic health record
- chronic kidney disease
- cardiovascular disease
- machine learning
- cell therapy
- stem cells
- left ventricular
- prognostic factors
- peritoneal dialysis
- patient reported outcomes
- artificial intelligence
- pain management